Abstract |
We reported a simple polydopamine (PDA)-based surface modification method to prepare novel targeted doxorubicin-loaded mesoporous silica nanoparticles and peptide CSNRDARRC conjugation (DOX-loaded MSNs@PDA-PEP) for enhancing the therapeutic effects on bladder cancer. Drug-loaded NPs were characterized in terms of size, size distribution, zeta potential, transmission electron microscopy (TEM), Brunauer-Emmett-Teller (BET) surface area and drug loading content. In vitro drug release indicated that DOX-loaded MSNs@PDA and MSNs@PDA-PEP had similar release kinetic profiles of DOX. The PDA coating well controlled DOX release and was highly sensitive to pH value. Confocal laser scanning microscopy (CLSM) showed that drug-loaded MSNs could be internalized by human bladder cancer cell line HT-1376, and DOX-loaded MSNs@PDA-PEP had the highest cellular uptake efficiency due to ligand-receptor recognition. The antitumor effects of DOX-loaded nanoparticles were evaluated by the MTT assay in vitro and by a xenograft tumor model in vivo, demonstrating that targeted nanocarriers DOX-loaded MSNs@PDA-PEP were significantly superior to free DOX and DOX-loaded MSNs@PDA. The novel DOX-loaded MSNs@PDA-PEP, which specifically recognized HT-1376 cells, can be used as a potential targeted drug delivery system for bladder cancer therapy.
|
Authors | Yi Wei, Li Gao, Lu Wang, Lin Shi, Erdong Wei, Baotong Zhou, Li Zhou, Bo Ge |
Journal | Drug delivery
(Drug Deliv)
Vol. 24
Issue 1
Pg. 681-691
(Nov 2017)
ISSN: 1521-0464 [Electronic] England |
PMID | 28414557
(Publication Type: Journal Article)
|
Chemical References |
- Drug Carriers
- Indoles
- Peptides
- Polymers
- polydopamine
- Silicon Dioxide
- Doxorubicin
|
Topics |
- Doxorubicin
- Drug Carriers
- Drug Delivery Systems
- Humans
- Indoles
- Nanoparticles
- Peptides
- Polymers
- Silicon Dioxide
- Urinary Bladder Neoplasms
|